Jordana Joy, Associate Editor

From new treatments on the horizon for macular degeneration to strengthening comanagement ties, optometrists cite a lot to be excited about in the coming year.

Catch up on what happened in optometry during the week of December 23-December 27.

One of the new resources are Spanish closed captioning on educational videos to expand their reach to Latin American countries.

Practice owners testify to the importance of trying new things, not being afraid to fail, and utilizing community as a resource when starting up a new practice.

If approved, Glaukos states that Epioxa would be the first FDA-approved, non-invasive corneal cross-linking therapy that does not require removal of the corneal epithelium.

Catch up on what happened in optometry during the week of December 16-December 20.

The American Optometric Association and Association of Armed Forces and Federal Optometric Services have advocated for the legislature’s passage.

Reviewing new AMD treatments and research can help optometrists prepare for what's to come in 2025.

Optometrists reflect on their residency experiences and provide advice to current residents.

EnVision Summit optometry faculty Sherrol Reynolds, OD, FAAO; Katie Rachon, OD, FAAO, Dipl ABO; Ashley Wallace-Tucker, OD, FAAO, FSLS, Dipl ABO; Jessica Steen, OD, FAAO, Dipl ABO; and Cecelia Koetting, OD, FAAO, Dipl ABO; express excitement for the upcoming conference and why optometrists should attend.

Mice with reduced levels of ERCC1-XPF in the study presented abnormal optokinetic and electroretinogram responses consistent with photoreceptor dysfunction and visual impairment.

Optometrists weigh in on the importance of building patient loyalty.

Catch up on what happened in optometry during the week of December 9-December 13.

Brush up your geographic atrophy knowledge with our 2024 content highlights.

All 6 biomarkers in the study demonstrated improvement with the treatment of lifitegrast, according to Thimons.

Catch up on what happened in optometry during the week of December 2-December 6.

The study found that the prosthetic replacement of the ocular surface ecosystem lenses were well tolerated in the delivery of non-preserved cyclosporine 0.05%.

In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.

Catch up on what happened in optometry during the week of November 25-November 29.

Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.

AOA members can receive a $1500 Visa gift card after signing up with Barti and being live on the platform for 3 months.

Optometric insights shine brighter than the lights on the Las Vegas Strip.

Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been recommending the NutriTears supplement to their dry eye patients.

The new board members were voted in on November 18 at an annual board meeting in Chicago, Illinois.

Catch up on what happened in optometry during the week of November 18-November 22.

Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent study that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.

The lid wipe contains tea tree oil, hyaluronic acid, and other antibacterial and antimicrobial ingredients like euphrasia, chamomile, and rhamnose

According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.

David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.

Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.